Which statement supports sample size justification?

Which statement supports sample size justification?

• A. The total enrollment across sites
• B. Clinical justification for the chosen sample size
• C. The marketing plan
• D. The post-trial data sharing plan

Answer: (B)

The main concept here is how a study determines how many participants to include in order to reliably answer its primary question. The justification for sample size must link the number of participants to the trial’s ability to detect a meaningful effect with adequate statistical power, based on expected effect size, variability, and acceptable error rates. The statement that provides clinical justification for the chosen sample size is the best because it ties the number of participants directly to the clinical objectives and the statistical plan. It explains why this many people are needed to have a high likelihood of detecting a true difference if one exists, given what the investigators expect about the treatment’s effect and the variability of the outcome. This is the core of ensuring the trial is neither underpowered (risking false negatives) nor unnecessarily large (exposing more participants than needed). The total enrollment across sites, while important for feasibility and logistics, does not by itself establish that the study has enough power to detect a meaningful difference. The marketing plan revolves around recruitment strategies and participant messaging, not the statistical rationale for sample size. The post-trial data sharing plan concerns dissemination and future use of results, not the study’s sizing. In practice, you justify sample size with a power calculation that uses the expected effect size, variability, the chosen significance level, and the desired power, and you account for possible dropouts and other design features. This ensures the study is ethically and scientifically able to address its primary objectives.

The main concept here is how a study determines how many participants to include in order to reliably answer its primary question. The justification for sample size must link the number of participants to the trial’s ability to detect a meaningful effect with adequate statistical power, based on expected effect size, variability, and acceptable error rates.

The statement that provides clinical justification for the chosen sample size is the best because it ties the number of participants directly to the clinical objectives and the statistical plan. It explains why this many people are needed to have a high likelihood of detecting a true difference if one exists, given what the investigators expect about the treatment’s effect and the variability of the outcome. This is the core of ensuring the trial is neither underpowered (risking false negatives) nor unnecessarily large (exposing more participants than needed).

The total enrollment across sites, while important for feasibility and logistics, does not by itself establish that the study has enough power to detect a meaningful difference. The marketing plan revolves around recruitment strategies and participant messaging, not the statistical rationale for sample size. The post-trial data sharing plan concerns dissemination and future use of results, not the study’s sizing.

In practice, you justify sample size with a power calculation that uses the expected effect size, variability, the chosen significance level, and the desired power, and you account for possible dropouts and other design features. This ensures the study is ethically and scientifically able to address its primary objectives.